glp 1 ra cardiovascular benefits GLP-1 Receptor Agonists in Heart Failure Management SGLTi and GLP-1 in HF

Ghazanfar H, Javed N, Qasim A, et al

Jennifer Hwang, DO Jennifer Hwang, DO, is a board-certified physician in internal medicine and obesity medicine and provides comprehensive primary care

Avoid injecting into skin that is red, bruised, tender, hard, scarred, or irritated

When calorie intake declines whether through semaglutide , tirzepatide , or other means the body prioritizes energy conservation

People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications

Example schedule: Weeks 1-3: Inject every 10 days instead of every 7